Analysts Viewpoint
ROIV’s short interest falls to 38.09 million shares
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Roivant Sciences Ltd revealed its President & Immunovant CEO Venker Eric unloaded Company’s shares for reported $1.15
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Roivant Sciences
Roivant Sciences Ltd’s filing revealed that its President & Immunovant CEO Venker Eric unloaded Company’s shares for reported $1.15 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its